Neeta Jain, M.D.

  1. Psychiatrist
  1. Craici I, Kadatz M, Klarenbach S, So H, Fervenza FC, Cattran DC, Barbour SJ, MENTOR Study Investigators. Rituximab or cyclosporine A for the treatment of membranous nephropathy: economic evaluation of the MENTOR trial. Nephrol Dial Transplant. 2024 Nov 27; 39 (12):2058-2066
    View PubMed
  2. Barbour SJ, Fervenza FC, Induruwage D, Brenchley PE, Rovin B, Hladunewich MA, Reich HN, Lafayette R, Aslam N, Appel GB, Zand L, Kiryluk K, Liu L, Cattran DC, MENTOR Trial Investigators. Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy. Clin J Am Soc Nephrol. 2023 Oct 1; 18 (10):1283-1293 Epub 2023 July 20
    View PubMed
  3. Sykora D, Stonnington CM, Jain N. An Agitated Patient With COVID-19 Infection and Early-onset Alzheimer Disease. Alzheimer Dis Assoc Disord. 2021 May 11 [Epub ahead of print]
    View PubMed
  4. Fervenza FC, Appel GB, Barbour SJ, Rovin BH, Lafayette RA, Aslam N, Jefferson JA, Gipson PE, Rizk DV, Sedor JR, Simon JF, McCarthy ET, Brenchley P, Sethi S, Avila-Casado C, Beanlands H, Lieske JC, Philibert D, Li T, Thomas LF, Green DF, Juncos LA, Beara-Lasic L, Blumenthal SS, Sussman AN, Erickson SB, Hladunewich M, Canetta PA, Hebert LA, Leung N, Radhakrishnan J, Reich HN, Parikh SV, Gipson DS, Lee DK, da Costa BR, Juni P, Cattran DC, MENTOR Investigators. Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy. N Engl J Med. 2019 Jul 4; 381 (1):36-46
    View PubMed